Skystar Bio Pharmaceutical Company Message Board

I looked through the presentation. The management looks fairly weak. The CFO is part-time CFO of another Chinese microcap (there isn't enough work for him at Skystar?). CFO's prior stint was as CFO of a secure credit card company that looks like it got driven into the ground. None of the management players look like A Team material.

The rest of presentation looks interesting, but how to verify any of it? Have you seen any credible third party analyst reports?

I believe they are being conservative on gross margins as there micro-organisim revenue is projected to be $11 million with 70% gross margin! That would be about a 50% increase as they have expanded capacity by 49%.